Cargando…

Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer

Background: The role of the androgen receptor (AR) in renal cell carcinoma (RCC) is unclear. We aimed to analyze the expression of AR and its splice variants (SVs) and their correlation with relaxin 2 (RLN2) and cytokines in RCC. Methods: We investigated the expression of RLN2 and AR variants in 25...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bialek, Joanna, Piwonka, Maria, Kawan, Felix, Fornara, Paolo, Theil, Gerit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402134/ https://www.ncbi.nlm.nih.gov/pubmed/34440475 http://dx.doi.org/10.3390/life11080731

Ejemplares similares

Role of Nivolumab in the Modulation of PD-1 and PD-L1 Expression in Papillary and Clear Cell Renal Carcinoma (RCC)
por: Bialek, Joanna, et al.
Publicado: (2022)

Potential Use of CTCs as Biomarkers in Renal Cancer Patients
por: Bialek, Joanna, et al.
Publicado: (2022)

Position of Circulating Tumor Cells in the Clinical Routine in Prostate Cancer and Breast Cancer Patients
por: Theil, Gerit, et al.
Publicado: (2020)

In vivo isolation of circulating tumor cells in patients with different stages of prostate cancer
por: Theil, Gerit, et al.
Publicado: (2021)

Strategies for Isolating and Propagating Circulating Tumor Cells in Men with Metastatic Prostate Cancer
por: Theil, Gerit, et al.
Publicado: (2022)

Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
por: Theil, Gerit, et al.
Publicado: (2021)

The Adipocyte-Derived Hormone Leptin Has Proliferative Actions on Androgen-Resistant Prostate Cancer Cells Linking Obesity to Advanced Stages of Prostate Cancer
por: Hoda, M. Raschid, et al.
Publicado: (2012)

Decoding the androgen receptor splice variants
por: Lu, Changxue, et al.
Publicado: (2013)

Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants
por: Speck, David, et al.
Publicado: (2022)

Expression of androgen receptor splice variants in clinical breast cancers
por: Hickey, Theresa E., et al.
Publicado: (2015)

Splice Variants of Androgen Receptor and Prostate Cancer
por: Caffo, Orazio, et al.
Publicado: (2016)

Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer
por: Sekine, Yoshitaka, et al.
Publicado: (2021)

Characterizing relaxin receptor expression and exploring relaxin’s effect on tissue remodeling/fibrosis in the human bladder
por: Diaz, Edward C., et al.
Publicado: (2020)

Role of androgen receptor splice variants in prostate cancer metastasis
por: Xu, Jin, et al.
Publicado: (2016)

Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy
por: Cao, Bo, et al.
Publicado: (2014)

Testosterone Reduces Knee Passive Range of Motion and Expression of Relaxin Receptor Isoforms via 5α-Dihydrotestosterone and Androgen Receptor Binding
por: Dehghan, Firouzeh, et al.
Publicado: (2014)

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
por: Sharp, Adam, et al.
Publicado: (2018)

The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study
por: Theil, Gerit, et al.
Publicado: (2016)

Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells
por: Rana, Manjul, et al.
Publicado: (2021)

Relaxin'
Publicado: (1983)

Relaxin
por: DeCherney, Alan H.
Publicado: (1982)

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?
por: Walters, Kirsty A, et al.
Publicado: (2016)

Androgen receptor splice variants and prostate cancer: From bench to bedside
por: Wadosky, Kristine M., et al.
Publicado: (2017)

Regulation of androgen receptor splice variant AR3 by PCGEM1
por: Zhang, Ziqiang, et al.
Publicado: (2016)

MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand
por: Liu, Gang, et al.
Publicado: (2014)

Examination of relaxin and its receptors expression in pig gametes and embryos
por: Feugang, Jean M, et al.
Publicado: (2011)

Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design
por: D'Ercole, Annunziata, et al.
Publicado: (2022)

Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer
por: Khan, Farhan, et al.
Publicado: (2023)

Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents
por: Zhang, Guanyi, et al.
Publicado: (2015)

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy
por: Messner, Elisabeth A., et al.
Publicado: (2020)

Androgen Receptor Splicing Variant-7 in Breast Cancer: Clinical and Pathologic Correlations
por: Ferguson, Donna C., et al.
Publicado: (2022)

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer
por: Tolkach, Yuri, et al.
Publicado: (2022)

Pinostilbene inhibits full-length and splice variant of androgen receptor in prostate cancer
por: Shin, Won Sik, et al.
Publicado: (2023)

Author Correction: Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells
por: Rana, Manjul, et al.
Publicado: (2021)

Cardioprotection Achieved Through Overexpression of Relaxin Receptors
por: Du, Xiao-Jun
Publicado: (2022)

Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
por: Bruell, Shoni, et al.
Publicado: (2017)

Characterization of relaxin 3 and its receptors in chicken: Evidence for relaxin 3 acting as a novel pituitary hormone
por: Lv, Can, et al.
Publicado: (2022)

AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression
por: Li, Yingming, et al.
Publicado: (2012)

Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
por: Hörnberg, Emma, et al.
Publicado: (2011)

Characterization of Prostate Cancer Bone Metastases According to Expression Levels of Steroidogenic Enzymes and Androgen Receptor Splice Variants
por: Jernberg, Emma, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_so8s4qoa4gon2l19fpdtjm61oq